News Category - Portfolio News - Vivo Capital | Healthcare Focused Investment Firm

Loading...

News

News Category – Portfolio Newsartrix2019-10-20T17:41:49-07:00

Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platform
Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platform

All News, Portfolio News, Vivo News

Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platform

April 21st, 2020|

RemeGen Completes USD $100 Million Plus in Funding
RemeGen Completes USD $100 Million Plus in Funding

All News, Portfolio News

RemeGen Completes USD $100 Million Plus in Funding

April 2nd, 2020|

Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors
Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors

All News, Portfolio News

Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors

November 11th, 2019|

AtriCure Enters Into Definitive Agreement to Acquire SentreHEART
AtriCure Enters Into Definitive Agreement to Acquire SentreHEART

All News, Portfolio News

AtriCure Enters Into Definitive Agreement to Acquire SentreHEART

August 12th, 2019|

Vivo Capital to Sponsor New Frontier Corporation’s Acquisition of United Family Healthcare
Vivo Capital to Sponsor New Frontier Corporation’s Acquisition of United Family Healthcare

All News, Portfolio News, Vivo News

Vivo Capital to Sponsor New Frontier Corporation’s Acquisition of United Family Healthcare

July 30th, 2019|

Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis
Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis

All News, Portfolio News

Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis

December 10th, 2018|

Impel NeuroPharma Closes $67.5 Million Series D Financing
Impel NeuroPharma Closes $67.5 Million Series D Financing

All News, Portfolio News, Vivo News

Impel NeuroPharma Closes $67.5 Million Series D Financing

December 6th, 2018|

Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraine
Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraine

All News, Portfolio News

Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraine

December 3rd, 2018|

Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China
Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China

All News, Portfolio News, Vivo News

Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China

November 8th, 2018|

Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancer
Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancer

All News, Portfolio News, Vivo News

Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancer

October 30th, 2018|

Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering
Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering

All News, Portfolio News

Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering

July 17th, 2018|

Sinovac Raises $86.73 Million Through Private Placement Transaction
Sinovac Raises $86.73 Million Through Private Placement Transaction

All News, Portfolio News, Vivo News

Sinovac Raises $86.73 Million Through Private Placement Transaction

July 3rd, 2018|

Tricida Announces Pricing of Initial Public Offering
Tricida Announces Pricing of Initial Public Offering

All News, Portfolio News

Tricida Announces Pricing of Initial Public Offering

June 27th, 2018|